Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2019. Start Trial.
Date Value
October 29, 2026 1.262
October 28, 2026 1.211
October 27, 2026 1.159
October 26, 2026 1.075
October 23, 2026 1.171
October 22, 2026 1.211
October 21, 2026 1.226
October 20, 2026 1.282
October 19, 2026 1.179
October 16, 2026 1.123
October 15, 2026 1.234
October 14, 2026 1.290
October 13, 2026 1.346
October 12, 2026 1.426
October 09, 2026 1.537
October 08, 2026 1.553
October 07, 2026 1.569
October 06, 2026 1.609
October 05, 2026 1.657
October 02, 2026 1.593
October 01, 2026 1.505
September 30, 2026 1.529
September 29, 2026 1.577
September 28, 2026 1.593
September 25, 2026 1.649
Date Value
September 24, 2026 1.716
September 23, 2026 1.768
September 22, 2026 1.991
September 21, 2026 1.959
September 18, 2026 2.031
September 17, 2026 2.055
September 16, 2026 1.983
September 15, 2026 2.067
September 14, 2026 2.318
September 11, 2026 2.174
September 10, 2026 2.182
September 09, 2026 2.318
September 08, 2026 2.604
September 04, 2026 2.764
September 03, 2026 2.772
September 02, 2026 2.843
September 01, 2026 2.628
August 31, 2026 2.477
August 28, 2026 2.485
August 27, 2026 2.692
August 26, 2026 2.588
August 25, 2026 2.565
August 24, 2026 2.469
August 21, 2026 2.493
August 20, 2026 2.541

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 21.31
Anika Therapeutics, Inc. 2.124
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 0.9278

Price to Book Value Related Metrics

Price 1.585
Earnings Yield -99.80%
Market Cap 265.85M